On ECHEMI
Home > Drugs > Hubei Weishi BIO-PHARMACEUTICAL Co., Ltd.
Hubei Weishi BIO-PHARMACEUTICAL Co., Ltd.
  • Founded in:

    1985-03-15
  • Country:

    China China
  • Address:

    No. 75, Ehuang Road, Huangshi City
  • Tax NO.:

    914202007809444236
  • Registered Funds:

    25.69 million yuan
  • Email:

Related Drugs
Procaine Hydrochloride Injection
Procadilol Hydrochloride
Name Description Content CAS NO. Registered Holders
Procadilol Hydrochloride

1. It has obvious bronchodilator effect; 2. The duration of bronchodilator effect is longer than that of other similar drugs; 3. It has superior selectivity for beta 2-receptors; 4. It has anti-allergic effect and can inhibit immediate and delayed increase in airway reactivity; 5. It promotes respiratory cilia movement and increases respiratory defense ability; 6. It may prevent or alleviate the occurrence of exercise-induced asthma.

More

1. It has obvious bronchodilator effect; 2. The duration of bronchodilator effect is longer than that of other similar drugs; 3. It has superior selectivity for beta 2-receptors; 4. It has anti-allergic effect and can inhibit immediate and delayed increase in airway reactivity; 5. It promotes respiratory cilia movement and increases respiratory defense ability; 6. It may prevent or alleviate the occurrence of exercise-induced asthma.

0
Osseous peptide injection
It includes organic calcium, phosphorus, inorganic calcium, inorganic salts, trace elements, amino acids, etc.
Name Description Content CAS NO. Registered Holders
Organic Calcium Boron Zinc

Regulate bone metabolism, promote new bone formation, increase bone calcium deposition, and prevent and treat osteoporosis

More

Regulate bone metabolism, promote new bone formation, increase bone calcium deposition, and prevent and treat osteoporosis

0
Phosphorus

Regulate calcium and phosphorus metabolism, prevent and treat osteoporosis

More

Regulate calcium and phosphorus metabolism, prevent and treat osteoporosis

7723-14-0 0
Inorganic perovskite quantum dots CSPBX3 (X is CL, BR, I halogen)

Regulate bone metabolism, promote new bone formation, increase bone calcium deposition, and prevent and treat osteoporosis

More

Regulate bone metabolism, promote new bone formation, increase bone calcium deposition, and prevent and treat osteoporosis

0
Inorganic salt

Participates in the regulation of bone metabolism

More

Participates in the regulation of bone metabolism

0
Trace Elements

Participate in the regulation of bone metabolism and prevent and treat osteoporosis

More

Participate in the regulation of bone metabolism and prevent and treat osteoporosis

0
L-tert-Leucine

Participate in the regulation of bone metabolism and stimulate osteoblast proliferation

More

Participate in the regulation of bone metabolism and stimulate osteoblast proliferation

20859-02-3 0
Active peptides for bone metabolism

Regulate bone metabolism, stimulate osteoblast proliferation, promote new bone formation, regulate calcium and phosphorus metabolism, increase bone calcium deposition, prevent and treat osteoporosis, anti-inflammatory, analgesic

More

Regulate bone metabolism, stimulate osteoblast proliferation, promote new bone formation, regulate calcium and phosphorus metabolism, increase bone calcium deposition, prevent and treat osteoporosis, anti-inflammatory, analgesic

0
Lincomycin Hydrochloride Injection
The main ingredient is lincomycin hydrochloride, and its chemical name is 6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-6,8-dideoxy-D-erythro-alpha;-D-galacto-octinopyranoside hydrochloride hydrate. Its structural formula is: Molecular formula: C18H34N2O6SHClH2O Molecular weight: 461.02
Name Description Content CAS NO. Registered Holders
Lincomycin hydrochloride

It has high antibacterial activity against common aerobic Gram-positive bacteria, such as Staphylococcus aureus (including those resistant to penicillin G), Staphylococcus epidermidis, beta-hemolytic Streptococcus, viridans Streptococcus and Streptococcus pneumoniae. It has good antibacterial effect on anaerobic bacteria, including Clostridium diphtheriae, and Clostridium perfringens. It has no activity against Gram-negative bacteria such as Enterococcus, meningococci, Neisseria gonorrhoeae, and Haemophilus influenzae, as well as fungi. There is no cross-resistance with penicillin, chloramphenicol, cephalosporins and tetracyclines, and there is partial cross-resistance with macrolides. It acts on the 50S subunit of the ribosome of sensitive bacteria, preventing the extension of the peptide chain, thereby inhibiting the protein synthesis of bacterial cells. It is generally an antibacterial agent, but at high concentrations, it also has a bactericidal effect on certain bacteria.

More

It has high antibacterial activity against common aerobic Gram-positive bacteria, such as Staphylococcus aureus (including those resistant to penicillin G), Staphylococcus epidermidis, beta-hemolytic Streptococcus, viridans Streptococcus and Streptococcus pneumoniae. It has good antibacterial effect on anaerobic bacteria, including Clostridium diphtheriae, and Clostridium perfringens. It has no activity against Gram-negative bacteria such as Enterococcus, meningococci, Neisseria gonorrhoeae, and Haemophilus influenzae, as well as fungi. There is no cross-resistance with penicillin, chloramphenicol, cephalosporins and tetracyclines, and there is partial cross-resistance with macrolides. It acts on the 50S subunit of the ribosome of sensitive bacteria, preventing the extension of the peptide chain, thereby inhibiting the protein synthesis of bacterial cells. It is generally an antibacterial agent, but at high concentrations, it also has a bactericidal effect on certain bacteria.

859-18-7 30
Lidocaine Hydrochloride Injection
The main ingredient of this product is lidocaine hydrochloride. Its chemical name is N-(dichloroxylyl)-2-(diethylamino)acetamide hydrochloride monohydrate.
Name Description Content CAS NO. Registered Holders
Lidocaine hydrochloride

This product is an amide local anesthetic, which has a biphasic effect of excitation and inhibition on the central nervous system. At low doses, it can promote the outflow of K in myocardial cells, reduce the autonomy of the myocardium, and has an anti-ventricular arrhythmia effect; at therapeutic doses, it has no obvious effect on the electrical activity of myocardial cells, atrioventricular conduction and myocardial contraction; when the blood drug concentration is further increased, it can cause a slowing of heart conduction velocity, atrioventricular conduction block, inhibit myocardial contractility and reduce cardiac output.

More

This product is an amide local anesthetic, which has a biphasic effect of excitation and inhibition on the central nervous system. At low doses, it can promote the outflow of K in myocardial cells, reduce the autonomy of the myocardium, and has an anti-ventricular arrhythmia effect; at therapeutic doses, it has no obvious effect on the electrical activity of myocardial cells, atrioventricular conduction and myocardial contraction; when the blood drug concentration is further increased, it can cause a slowing of heart conduction velocity, atrioventricular conduction block, inhibit myocardial contractility and reduce cardiac output.

6108-05-0 45
Snake Gallbladder and Fritillaria Capsules
Fritillaria cirrhosa and snake bile.
Name Description Content CAS NO. Registered Holders
Dehydroandrographolide

134418-28-3 0
D-(-)-Tartaric Acid

147-71-7 1
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.